KEGG   PATHWAY: xla04115
Entry
xla04115                    Pathway                                
Name
p53 signaling pathway - Xenopus laevis (African clawed frog)
Description
p53 activation is induced by a number of stress signals, including DNA damage, oxidative stress and activated oncogenes. The p53 protein is employed as a transcriptional activator of p53-regulated genes. This results in three major outputs; cell cycle arrest, cellular senescence or apoptosis. Other p53-regulated gene functions communicate with adjacent cells, repair the damaged DNA or set up positive and negative feedback loops that enhance or attenuate the functions of the p53 protein and integrate these stress responses with other signal transduction pathways.
Class
Cellular Processes; Cell growth and death
Pathway map
xla04115  p53 signaling pathway
xla04115

Organism
Xenopus laevis (African clawed frog) [GN:xla]
Gene
100036910  casp3.2.L; uncharacterized protein LOC100036910 [KO:K02187] [EC:3.4.22.56]
100037065  siva1.L; SIVA1, apoptosis-inducing factor L homeolog [KO:K22744]
100049086  aifm2.S; ferroptosis suppressor protein 1 [KO:K22745]
100049128  siva1.S; uncharacterized protein LOC100049128 [KO:K22744]
100049768  serpine1.S; plasminogen activator inhibitor 1 [KO:K03982]
100158422  cop1.L; E3 ubiquitin-protein ligase COP1 isoform X2 [KO:K10143] [EC:2.3.2.27]
100271914  bcl2.S; B-cell CLL/lymphoma 2 S homeolog [KO:K02161]
100505440  pten.S; uncharacterized protein LOC100505440 [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
101027271  gadd45b.S; growth arrest and DNA damage inducible beta S homeolog [KO:K04402]
108695407  [KO:K10808] [EC:1.17.4.1]
108695463  [KO:K04596]
108696050  [KO:K04390]
108696268  aifm2.L; ferroptosis suppressor protein 1 [KO:K22745]
108696394  chek1.L; serine/threonine-protein kinase Chk1-like isoform X1 [KO:K02216] [EC:2.7.11.1]
108696395  ei24.L; etoposide-induced protein 2.4 homolog [KO:K10134]
108696624  tp73.L; tumor protein p73 isoform X1 [KO:K10148]
108696744  bax.L; apoptosis regulator BAX-like [KO:K02159]
108697171  [KO:K04390]
108697705  [KO:K10148]
108700197  ppp1r13l.S; relA-associated inhibitor isoform X2 [KO:K27356]
108700971  [KO:K04570]
108701235  steap3.L; metalloreductase STEAP3 isoform X1 [KO:K10142] [EC:1.16.1.-]
108701656  tsc2.L; tuberin isoform X3 [KO:K07207]
108702018  [KO:K10128]
108702402  rprm.S; protein reprimo [KO:K10128]
108703213  tsc2.S; tuberin isoform X1 [KO:K07207]
108703451  tp53.S; cellular tumor antigen p53-like [KO:K04451]
108704383  bid.L; BH3-interacting domain death agonist isoform X1 [KO:K04726]
108706001  [KO:K19748]
108708631  znf385a.L; zinc finger protein 385A isoform X1 [KO:K26543]
108709405  cdkn1a.S; cyclin-dependent kinase inhibitor 1 [KO:K06625]
108709889  znf385a.S; zinc finger protein 385A isoform X1 [KO:K26543]
108710010  sesn3.S; sestrin-3 [KO:K10141]
108711020  igf1.S; insulin-like growth factor I-A [KO:K05459]
108711092  mdm2.L; E3 ubiquitin-protein ligase Mdm2-like isoform X1 [KO:K06643] [EC:2.3.2.27]
108712402  gadd45b.L; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
108712492  [KO:K05459]
108713153  [KO:K06643] [EC:2.3.2.27]
108713786  ddb2.L; DNA damage-binding protein 2 [KO:K10140]
108713866  pidd1.L; p53-induced death domain-containing protein 1 isoform X1 [KO:K10130]
108714209  gadd45a.L; growth arrest and DNA damage-inducible protein GADD45 alpha isoform X1 [KO:K04402]
108714491  gorab.L; RAB6-interacting golgin isoform X1 [KO:K19748]
108715228  ddb2.S; LOW QUALITY PROTEIN: DNA damage-binding protein 2 [KO:K10140]
108715479  siah1.S; E3 ubiquitin-protein ligase SIAH1 isoform X1 [KO:K04506] [EC:2.3.2.27]
108715625  cop1.S; E3 ubiquitin-protein ligase COP1 isoform X1 [KO:K10143] [EC:2.3.2.27]
108717942  sesn1.S; sestrin-1-like [KO:K10141]
108718066  ccnb1.L; G2/mitotic-specific cyclin-B1-like [KO:K05868]
108718092  zmat3.S; zinc finger matrin-type protein 3 [KO:K10137]
108718479  [KO:K02091] [EC:2.7.11.22]
108718612  [KO:K04596]
108718725  serpinb5.L; serpin B5 [KO:K10139]
108718882  cycs.L; cytochrome c, testis-specific [KO:K08738]
108719105  bcl2.L; apoptosis regulator Bcl-2 [KO:K02161]
108719900  [KO:K02091] [EC:2.7.11.22]
373559  casp8.L; caspase 8 L homeolog [KO:K04398] [EC:3.4.22.61]
373560  casp9.S; caspase 9 S homeolog [KO:K04399] [EC:3.4.22.62]
373637  bax.S; BCL2-associated X protein L homeolog [KO:K02159]
373667  ccnd2.L; G1/S-specific cyclin-D2 [KO:K10151]
379056  rrm2b.S; ribonucleotide reductase M2 B (TP53 inducible) S homeolog [KO:K10808] [EC:1.17.4.1]
379161  ccnd1.S; G1/S-specific cyclin-D1 b [KO:K04503]
379224  gadd45a.S; growth arrest and DNA damage inducible alpha S homeolog [KO:K04402]
379285  gadd45g.S; uncharacterized protein LOC379285 [KO:K04402]
379404  ccng1.L; cyclin G1 L homeolog [KO:K10145]
379406  cdk4.S; cyclin-dependent kinase 4 [KO:K02089] [EC:2.7.11.22]
379508  thbs1.L; thrombospondin 1 L homeolog precursor [KO:K16857]
379559  sesn1.L; sestrin-1 [KO:K10141]
379785  cdk1.L; cyclin-dependent kinase 1-B [KO:K02087] [EC:2.7.11.22 2.7.11.23]
379888  ccnb1.2.L; cyclin B1 L homeolog [KO:K05868]
379937  ccnd1.L; G1/S-specific cyclin-D1 [KO:K04503]
380219  ccne2.L; cyclin E2 L homeolog [KO:K06626]
380246  cdk1.S; cyclin-dependent kinase 1-A [KO:K02087] [EC:2.7.11.22 2.7.11.23]
380383  ppm1d.S; protein phosphatase, Mg2+/Mn2+ dependent 1D S homeolog [KO:K10147] [EC:3.1.3.16]
380465  rrm2.2.L; ribonucleotide reductase M2 polypeptide [KO:K10808] [EC:1.17.4.1]
397720  casp3.2.S; caspase-3 [KO:K02187] [EC:3.4.22.56]
397742  ccnb1.2.S; G2/mitotic-specific cyclin-B1 [KO:K05868]
397743  ccnb2.S; G2/mitotic-specific cyclin-B2 [KO:K21770]
397840  ccne1.L; G1/S-specific cyclin-E1 [KO:K06626]
397841  ccne1.S; G1/S-specific cyclin-E3 [KO:K06626]
397926  tp53.L; cellular tumor antigen p53 [KO:K04451]
398148  atm.L; ATM serine/threonine kinase L homeolog [KO:K04728] [EC:2.7.11.1]
398162  [KO:K21770]
398163  ccnb1.S; cyclin B1 S homeolog [KO:K05868]
398179  chek2.L; checkpoint kinase 2 L homeolog [KO:K06641] [EC:2.7.11.1]
398191  chek1.S; serine/threonine-protein kinase Chk1 [KO:K02216] [EC:2.7.11.1]
398197  atr.L; serine/threonine-protein kinase atr [KO:K06640] [EC:2.7.11.1]
398251  bcl2l1.S; apoptosis regulator R11 [KO:K04570]
398466  mdm4.S; protein Mdm4 [KO:K10127]
398888  ccnb2.L; uncharacterized protein LOC398888 [KO:K21770]
399142  pten.L; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
399196  gadd45g.L; growth arrest and DNA damage inducible gamma L homeolog [KO:K04402]
399314  cdk2.S; cyclin-dependent kinase 2 [KO:K02206] [EC:2.7.11.22]
404688  tnfrsf10b.L; tumor necrosis factor receptor superfamily member 10b L homeolog precursor [KO:K04722]
414641  sesn2.L; sestrin 2 L homeolog [KO:K20394]
414705  cyct.L; cytochrome c, somatic B [KO:K08738]
431934  ccng2.S; cyclin G2 S homeolog [KO:K10146]
432036  cdk2.L; uncharacterized protein LOC432036 [KO:K02206] [EC:2.7.11.22]
432226  cd82.L; uncharacterized protein LOC432226 [KO:K06509]
443672  sesn2.S; sestrin-2 [KO:K20394]
443815  rrm2.1.L; ribonucleotide reductase M2, gene 1 L homeolog [KO:K10808] [EC:1.17.4.1]
443864  siah1.L; siah E3 ubiquitin protein ligase 1 L homeolog [KO:K04506] [EC:2.3.2.27]
443888  cyct.S; cytochrome c, somatic A [KO:K08738]
443904  sesn3.L; sestrin-3 [KO:K10141]
443988  ppm1d.L; protein phosphatase 1D [KO:K10147] [EC:3.1.3.16]
444244  cd82.S; CD82 molecule S homeolog [KO:K06509]
444261  apaf1.L; apoptotic peptidase activating factor 1 L homeolog [KO:K02084]
444383  tp53i3.S; tumor protein p53 inducible protein 3 S homeolog [KO:K10133] [EC:1.-.-.-]
444530  cycs.S; cytochrome c, testis-specific [KO:K08738]
444607  ccng2.L; cyclin G2 L homeolog [KO:K10146]
444660  perp.S; PERP, TP53 apoptosis effector S homeolog [KO:K10136]
444699  serpinb5.S; serpin B5 [KO:K10139]
447427  ppp1r13l.L; protein phosphatase 1 regulatory subunit 13 like L homeolog [KO:K27356]
447452  gtse1.S; G2 and S-phase expressed 1 S homeolog [KO:K10129]
447541  [KO:K04503]
447748  ccndx.L; G1/S-specific cyclin-D1 [KO:K04503]
492305  cdkn1a.L; cyclin-dependent kinase inhibitor 1 [KO:K06625]
495297  ei24.S; etoposide induced 2.4 S homeolog [KO:K10134]
495419  ccne2.S; uncharacterized protein LOC495419 [KO:K06626]
496013  rchy1.L; ring finger and CHY zinc finger domain containing 1 L homeolog [KO:K10144] [EC:2.3.2.27]
496334  cdk6.L; cyclin-dependent kinase 6 L homeolog [KO:K02089] [EC:2.7.11.22]
724076  bid.S; BH3 interacting domain death agonist S homeolog [KO:K04726]
734417  gtse1.L; G2 and S-phase expressed 1 L homeolog [KO:K10129]
734854  zmat3.L; zinc finger matrin-type 3 L homeolog [KO:K10137]
734882  ccnd2.S; cyclin D2 S homeolog [KO:K10151]
779026  thbs1.S; thrombospondin-1 [KO:K16857]
779347  ccng1.S; cyclin G1 S homeolog [KO:K10145]
779433  serpine1.L; serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 L homeolog precursor [KO:K03982]
Reference
  Authors
Levine AJ, Hu W, Feng Z.
  Title
The P53 pathway: what questions remain to be explored?
  Journal
Cell Death Differ 13:1027-36 (2006)
DOI:10.1038/sj.cdd.4401910
Reference
  Authors
Harris SL, Levine AJ.
  Title
The p53 pathway: positive and negative feedback loops.
  Journal
Oncogene 24:2899-908 (2005)
DOI:10.1038/sj.onc.1208615
Reference
  Authors
Balint E E, Vousden KH.
  Title
Activation and activities of the p53 tumour suppressor protein.
  Journal
Br J Cancer 85:1813-23 (2001)
DOI:10.1054/bjoc.2001.2128
Reference
  Authors
Taylor WR, Stark GR.
  Title
Regulation of the G2/M transition by p53.
  Journal
Oncogene 20:1803-15 (2001)
DOI:10.1038/sj.onc.1204252
Reference
  Authors
Hofseth LJ, Hussain SP, Harris CC.
  Title
p53: 25 years after its discovery.
  Journal
Trends Pharmacol Sci 25:177-81 (2004)
DOI:10.1016/j.tips.2004.02.009
Reference
  Authors
Pietenpol JA, Stewart ZA.
  Title
Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis.
  Journal
Toxicology 181-182:475-81 (2002)
DOI:10.1016/S0300-483X(02)00460-2
Reference
  Authors
Tokino T, Nakamura Y.
  Title
The role of p53-target genes in human cancer.
  Journal
Crit Rev Oncol Hematol 33:1-6 (2000)
DOI:10.1016/S1040-8428(99)00051-7
Reference
  Authors
Hermeking H, Benzinger A.
  Title
14-3-3 proteins in cell cycle regulation.
  Journal
Semin Cancer Biol 16:183-92 (2006)
DOI:10.1016/j.semcancer.2006.03.002
Reference
  Authors
Sherr CJ.
  Title
Divorcing ARF and p53: an unsettled case.
  Journal
Nat Rev Cancer 6:663-73 (2006)
DOI:10.1038/nrc1954
Reference
  Authors
Feng Z, Hu W, de Stanchina E, Teresky AK, Jin S, Lowe S, Levine AJ.
  Title
The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways.
  Journal
Cancer Res 67:3043-53 (2007)
DOI:10.1158/0008-5472.CAN-06-4149
Reference
  Authors
Resnick-Silverman L, Manfredi JJ
  Title
Two Faces of SIVA.
  Journal
Cancer Discov 5:581-3 (2015)
DOI:10.1158/2159-8290.CD-15-0484
Reference
  Authors
Resch U, Schichl YM, Winsauer G, Gudi R, Prasad K, de Martin R
  Title
Siva1 is a XIAP-interacting protein that balances NFkappaB and JNK signalling to promote apoptosis.
  Journal
J Cell Sci 122:2651-61 (2009)
DOI:10.1242/jcs.049940
Reference
  Authors
Barkinge JL, Gudi R, Sarah H, Chu F, Borthakur A, Prabhakar BS, Prasad KV
  Title
The p53-induced Siva-1 plays a significant role in cisplatin-mediated apoptosis.
  Journal
J Carcinog 8:2 (2009)
DOI:10.4103/1477-3163.45389
Reference
  Authors
Ohiro Y, Garkavtsev I, Kobayashi S, Sreekumar KR, Nantz R, Higashikubo BT, Duffy SL, Higashikubo R, Usheva A, Gius D, Kley N, Horikoshi N
  Title
A novel p53-inducible apoptogenic gene, PRG3, encodes a homologue of the apoptosis-inducing factor (AIF).
  Journal
FEBS Lett 524:163-71 (2002)
DOI:10.1016/S0014-5793(02)03049-1
Reference
  Authors
Hu Y, Ge W, Wang X, Sutendra G, Zhao K, Dedeic Z, Slee EA, Baer C, Lu X
  Title
Caspase cleavage of iASPP potentiates its ability to inhibit p53 and NF-kappaB.
  Journal
Oncotarget 6:42478-90 (2015)
DOI:10.18632/oncotarget.6478
Related
pathway
xla04110  Cell cycle
xla04210  Apoptosis
xla04218  Cellular senescence
KO pathway
ko04115   

DBGET integrated database retrieval system